Based on the finding that pharmacological inhibition of DAPK1 activity produces rapid and potent antiseizure effects in both PTZ-induced acute and kindling animal models, DAPK1 inhibition might be a promising option for epilepsy interventions. The gene discussed is DAPK1; the disease is epilepsy.